Alessio Mazzoni to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications Alessio Mazzoni has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.093
-
Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab. PLoS Pathog. 2021 02; 17(2):e1009243.
Score: 0.047
-
Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab. Immunol Lett. 2020 12; 228:122-128.
Score: 0.046